Mus vs Palestine: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
Mus
96.0%
in 2025
Palestine
99.0%
in 2025
Mus rank
1st
Palestine rank
1st
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- Mus
- Palestine
How they compare
Palestine currently reports 99.0% against 96.0% in Mus, a difference of 3.0%.
The two have swapped places 8 times across 26 shared years of data; in 2000 it was Palestine ahead.
Mus ranks 1st and Palestine ranks 1st of 2 regions.
Palestine has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Palestine | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.4% | 96.5% | 1.1% | Palestine |
| 2010s | 97.0% | 98.8% | 1.8% | Palestine |
| 2020s | 95.0% | 96.2% | 1.2% | Palestine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), Mus or Palestine?
- Palestine, at 99.0% against 96.0% in Mus as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between Mus and Palestine?
- 3.0%, with Palestine ahead.
- How many years of comparable data are there for Mus and Palestine?
- 26 years are reported by both, from 2000 to 2025.
- How do Mus and Palestine rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Mus ranks 1st and Palestine ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.